Nexplanon® (etonogestrel) Training Support Programme (NTSP)

Click here for prescribing information Adverse Events Reporting

Are you interested in becoming a Nexplanon® (etonogestrel) implant fitter / remover?

NEXPLANON® (etonogestrel 68 mg implant) is indicated for contraception.
Safety and efficacy have been established in women between 18 and 40 years of age.1

The Nexplanon Training Support Programme (NTSP) is fully funded by Organon and forms part of a commercial arrangement.

Please contact a representative to find out more.

Contact a Representative
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk
or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Organon Pharma (UK) Limited. (Tel: 02081 593593). By clicking the above link you will leave the Organon website and be taken to the MHRA website.

References:

  1. NEXPLANON® Summary of Product Characteristics
GB-XPL-115637 | Date of preparation January 2025